Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7Polycystic Ovary Syndrome 4Prostatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Rectal Neoplasms 1Psoriasis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasms 1Neoplasm, Residual 1Multiple Sclerosis 1Lipid Metabolism Disorders 1Inflammation 1Healthy Subject 1Dyspareunia 1Diabetes Mellitus 1Crohn Disease 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Breast Feeding 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Aggressive Periodontitis 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Fish Oils × Clear all
NCT04699760 2021-01-07

The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer

University of Copenhagen

Phase 4 Completed
50 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡